Narcobarbital

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Narcobarbital
Narcobarbital.svg
Clinical data
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
KEGG
ChEMBL
Chemical and physical data
Formula C11H15BrN2O3
Molar mass 303.152 g/mol
3D model (JSmol)
  (verify)

Narcobarbital (Pronarcon) is a barbiturate derivative developed in 1932 by Carl Heinrich Friedrich Boedecker and Heinrich Gruber Schoneberg, assignors to the firm J. D. Riedel-E. de Haën AG, Berlin, Germany. Later, in 1937, may, was patented in United States.[1] It is an N-methylated derivative of propallylonal and has similar sedative effects. It is still used in veterinary medicine for inducing surgical anaesthesia.[2]


References[edit]

  1. ^ US Patent 2080071
  2. ^ N/A (1999). "Position Paper on availability of Veterinary Medicines agreed on 17 March 1999" (PDF (Public access)). Committee For Veterinary Medicinal Products: 3–8.